Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role and Mechanism of MMR/MSI Phenotypes in Evaluating Vaccine Benefit in Glioblastoma

NCT06043232 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.

NCT NCT06043232
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06043232 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role and Mechanism of MMR/MSI Phenotypes in Evaluating Vaccine Benefit in Glioblastoma
Lead sponsor
Huashan Hospital
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2023
Completion date
March 31, 2026
Enrollment
360 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glioma